Overview

Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma

Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to study how helpful thalidomide is in controlling the myeloma disease and to study any side effect resulting from thalidomide.
Phase:
Phase 2
Details
Lead Sponsor:
University of Arkansas
Treatments:
Thalidomide